NOTHING DISCUSSED IN THIS PODCAST IS MEDCAL ADVICE In this weeks episode of Bioactive Riley (@cannabichem) talks with Chris Witowski the CEO and cofounder of the biotech company Psilera investigating new psychedelic substances for the treatment of conditions like anxiety, depression, and PTSD. Chris discusses the general pipeline for how Psilera goes about investigating new drug candidates as well as the advantages to non-hallucinogenic psychedelic drugs. Thanks for listening and subscribing to this channel- mad love Reach Chris and the rest of the Psilera team at: [email protected] twitter: @Psilera IG: @Psilera Papers discussed in this episode: "Psychedelics promote plasticity by directly binding to BDNF receptor TrkB" https://www.nature.com/articles/s4159...
Thank you to our podcast sponsor Boveda, and check out humidity packs for your cannabis at https://bovedainc.com/
Learn more about your ad choices. Visit megaphone.fm/adchoices

Ver todos los episodios